Notice2023-02921
Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 10, 2023
Issuing agencies
Health and Human Services Department
Abstract
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The meeting will be held in-person at the Hubert H. Humphrey building in Washington, DC, and will be open to the public; the meeting will be streamed live on hhs.gov/live. A pre-registered public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to present their comments in-person at the meeting. Individuals who wish to send in their written public comment should send an email to CARB@hhs.gov. Registration information is available on the website http://www.hhs.gov/paccarb and must be completed by March 17, 2023 for the March 23-24, 2023 Public Meeting. Additional information about registering for the meeting and providing public comment can be obtained at http://www.hhs.gov/paccarb on the Upcoming Meetings page.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 28 (Friday, February 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 28 (Friday, February 10, 2023)]
[Notices]
[Pages 8873-8874]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-02921]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meetings of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting is scheduled to be held for the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The
meeting will be held in-person at the Hubert H. Humphrey building in
Washington, DC, and will be open to the public; the meeting will be
streamed live on <a href="http://hhs.gov/live">hhs.gov/live</a>. A pre-registered public comment session
will be held during the meeting. Pre-registration is required for
members of the public who wish to present their comments in-person at
the meeting. Individuals who wish to send in their written public
comment should send an email to <a href="/cdn-cgi/l/email-protection#84c7c5d6c6c4ececf7aae3ebf2"><span class="__cf_email__" data-cfemail="5516140717153d3d267b323a23">[email protected]</span></a>. Registration information
is available on the website <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> and must be
completed by March 17, 2023 for the March 23-24, 2023 Public Meeting.
Additional information about registering for the meeting and providing
public comment can be obtained at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> on the
Upcoming Meetings page.
DATES: The meeting is scheduled to be held on March 23-24, 2023, from
10 a.m. to 4 p.m. ET (times are tentative and subject to change). The
confirmed times and agenda items for the meeting will be posted on the
website for the PACCARB at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> when this
information becomes available. Pre-registration for attending the
meeting is strongly suggested and should be completed no later than
March 17, 2023.
ADDRESSES: U.S. Department of Health and Human Services, Hubert H.
Humphrey Building, Great Hall, 200 Independence Avenue SW, Washington,
DC 20201. All in-person attendees must have a valid U.S. government
issued I.D. to enter the building. All non-U.S. citizen in-person
attendees must contact <a href="/cdn-cgi/l/email-protection#5417150616143c3c277a333b22"><span class="__cf_email__" data-cfemail="d39092819193bbbba0fdb4bca5">[email protected]</span></a> at least two weeks prior to the
meeting to accommodate the HHS security vetting process. The meeting
can also be accessed through a live webcast on the day of the meeting.
Additional instructions regarding attending this meeting virtually will
be
[[Page 8874]]
posted at least one week prior to the meeting at: <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202-746-1512; Email: <a href="/cdn-cgi/l/email-protection#1a595b48585a727269347d756c"><span class="__cf_email__" data-cfemail="1e5d5f4c5c5e76766d30797168">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are
governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth
standards for the formation and use of federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary of Health and Human Services
(Secretary) regarding programs and policies intended to reduce or
combat antibiotic-resistant bacteria that may present a public health
threat and improve capabilities to prevent, diagnose, mitigate, or
treat such resistance. The PACCARB shall function solely for advisory
purposes.
Such advice, information, and recommendations may be related to
improving: the effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The March 23-24, 2023 will be a two-day meeting that will focus on
the report out from the Pandemic Preparedness Working Group as they
present their findings in response to the 2022 task from the HHS
Secretary in a report with recommendations to the full PACCARB for
deliberation and vote. Upon completion of the voting process, the
PACCARB will honor its retiring members. The meeting will also include
updates from the international sector on progress in the ongoing fight
against antimicrobial resistance and an exploration of future topics
for the PACCARB to consider in the following year. The meeting agenda
will be posted on the PACCARB website at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>
when it has been finalized. All agenda items are tentative and subject
to change. Instructions regarding attending the meeting virtually will
be posted at least one week prior to the meeting at: <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
Members of the public will have the opportunity to provide comments
in-person during the March meeting by pre-registering online at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>. Pre-registration is required for participation in
this session with limited spots available. Written public comments can
also be emailed to <a href="/cdn-cgi/l/email-protection#480b091a0a0820203b662f273e"><span class="__cf_email__" data-cfemail="e6a5a7b4a4a68e8e95c8818990">[email protected]</span></a> by midnight March 17, 2023 and should
be limited to no more than one page. All public comments received prior
to March 17, 2023, will be provided to the PACCARB members.
Additionally, companies and/or organizations involved in combating
antibiotic resistance have an opportunity to present their work to
members of the PACCARB live during an Innovation Spotlight. Pre-
registration is required for participation, with limited spots
available. All information regarding this session can also be found
online at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
Dated: January 12, 2023.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2023-02921 Filed 2-9-23; 8:45 am]
BILLING CODE 4150-44-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 10, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.